NCT00852826已完成4 期
Value of a Hemostatic and Sealing Agent for Preventing Seroma After Axillary Lymphadenectomy
Hospital Universitario Virgen de la Arrixaca2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2008年1月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
- 试验地点
- 2
研究概览
简要总结
This study was intended to assess the value of a hemostatic and sealing agent, a collagen sponge coated with human coagulation factors (fibrinogen and thrombin) (TachoSil®), for decreasing occurrence of seroma after axillary lymphadenectomy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with axillary lymphadenectomies performed for oncological conditions.
排除标准
- •Patients that did not want to participate in the study.
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Prospective Clinical Trial of the Hemopatch Topic Hemostatic in Cardiac SurgeryBleedingNCT02133378Cardiochirurgia E.H.170
已完成
4 期
Tissue Sealant Use in LASIK Enhancement SurgeryEpithelial IngrowthNCT02952365Stanford University2
尚未招募
不适用
Effect dressing material on blood clotting time.CTRI/2021/04/033048alit Kumar
撤回
4 期
Benefit of Topical Hemostatic Powder Containing Hydrophilic Polymer With Potassium Ferrate for Hemostasis Following Nail SurgeryNail DiseasesNCT04384679Weill Medical College of Cornell University
Unknown
不适用
Assessment of the Usefulness of Hemopatch in Coronary Artery Bypass Graft SurgeryCHD - Coronary Heart DiseaseNCT03340090Medical University of Lodz200